Tango Therapeutics Inc (TNGX) Stock Analysis
Verdict: WATCH (do not buy)
Strong synthetic lethality platform and $353.8M liquid assets offset high 70.7x P/S valuation and $139.9M annual cash burn.
Investment score: 45/100
Analysis as of
Is Tango Therapeutics Inc stock worth reviewing? AI model thesis
TNGX presents compelling early-stage synthetic lethality data backed by Gilead, but high valuation multiples (70.7x P/S) and ongoing cash burn (-$139.9M FCF) justify a neutral HOLD rating.
7-factor investment score
- Valuation: 35/100 (weight 20%)
- Financial Health: 50/100 (weight 15%)
- Technical Momentum: 40/100 (weight 15%)
- Earnings Quality: 45/100 (weight 15%)
- Insider Sentiment: 20/100 (weight 10%)
- Analyst Consensus: 85/100 (weight 10%)
- Risk-Adjusted Return: 45/100 (weight 15%)
Tango Therapeutics Inc opportunities and risks
What speaks for TNGX
- Strategic Partnership with Gilead Sciences provides cost-sharing and milestone potential
What speaks against TNGX
- High binary risk associated with clinical-stage oncology drug candidates
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| TNGX | n/a | 70.6x | n/a | 98.2% | -229.9% | -3.8% |
| IOVA | n/a | 13.6x | n/a | 116.3% | -89.1% | -6.7% |
| RLAY | n/a | 398.9x | n/a | -566.6% | -2763.6% | -5.1% |
| CELC | n/a | 0.0x | n/a | 0.0% | 0.0% | -4.8% |
| IDYA | n/a | 15.3x | n/a | -13.3% | -74.8% | -5.3% |
| VKTX | n/a | 0.0x | n/a | 0.0% | 0.0% | -12.2% |
| Peer median | n/a | 13.6x | n/a | 0.0% | -74.8% | -5.3% |
Frequently asked questions about Tango Therapeutics Inc (TNGX)
Is TNGX stock a good investment?
The cached TradeMates AI model rates Tango Therapeutics Inc as WATCH (do not buy) with an investment score of 45/100. TNGX presents compelling early-stage synthetic lethality data backed by Gilead, but high valuation multiples (70.7x P/S) and ongoing cash burn (-$139.9M FCF) justify a neutral HOLD rating. This is algorithmic model output, not personal investment advice.
Is TNGX stock a buy?
The TradeMates model verdict for TNGX is WATCH (do not buy) with an investment score of 45/100. Treat this as a model signal to review, not a personal buy recommendation.